Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-15 Huber Martin H. Jr. Director Grant or award · Stock Options (Right to buy) +35,000 $19.36 $678K 35,000
2021-09-14 Metzger Michael A President and COO Option exercise +44,349 $7.20 $319K 62,008
2021-09-14 Metzger Michael A President and COO Sale −44,349 $19.15 $849K 17,659
2021-09-14 Metzger Michael A President and COO Option exercise · Stock Options (Right to buy) −44,349 0
2021-09-13 Metzger Michael A President and COO Option exercise +16,651 $7.20 $120K 34,310
2021-09-13 Metzger Michael A President and COO Sale −16,651 $19.02 $317K 17,659
2021-09-13 Metzger Michael A President and COO Option exercise · Stock Options (Right to buy) −16,651 0
2021-08-18 Egros Fabrice Director Option exercise +15,635 $7.88 $123K 31,635
2021-08-18 Egros Fabrice Director Sale −15,635 $15.75 $246K 16,000
2021-08-18 Egros Fabrice Director Option exercise · Stock Options (Right to buy) −15,635 0
2021-05-18 Egros Fabrice Director Option exercise +11,926 $7.20 $86K 27,926
2021-05-18 Egros Fabrice Director Option exercise +1,683 $7.88 $13K 29,609
2021-05-18 Egros Fabrice Director Sale −11,926 $18.65 $222K 17,683
2021-05-18 Egros Fabrice Director Sale −1,683 $18.65 $31K 16,000
2021-05-18 Egros Fabrice Director Option exercise · Stock Options (Right to buy) −1,683 0
2021-05-18 Egros Fabrice Director Option exercise · Stock Options (Right to buy) −11,926 0
2021-04-26 Meyers Michael L. SVP, Chief Medical Officer Purchase +500 $15.46 $8K 15,666
2021-04-22 Podlesak Dennis Director Purchase +13,967 $14.11 $197K 43,300
2021-03-01 Egros Fabrice Director Option exercise +10,167 $6.35 $65K 26,167
2021-03-01 Egros Fabrice Director Option exercise +74 $7.20 $533 26,241

Page 19 of 25 · 500 trades